Aug 16 (Reuters) - Omega Diagnostics Group PLC ODX.L :
* RE. RESULTS, TRADING UPDATE & NIGERIAN CD4 ORDER
* TRADING IN Q1 OF NEW FINANCIAL YEAR WITH OUR CORE BUSINESS
LINE WITH MANAGEMENT EXPECTATIONS.
* FY TURNOVER EXPECTED TO BE £9.76M (2018: £13.55M),
TURNOVER FROM
CONTINUING OPERATIONS IS EXPECTED TO BE 5% HIGHER AT £8.76M
(2018: £8.33M)
* FY ADJUSTED LOSS BEFORE TAX FROM CONTINUING OPERATIONS IS
EXPECTED TO BE £0.2M (2018: LOSS OF £1.0M).
* DEFERRED RELEASING RESULTS TO GIVE MORE TIME FOR CLARITY
ON SOME
ONGOING COMMERCIAL TALKS, OTHER POST-BALANCE SHEET EVENTS
* GOT PURCHASE ORDER FROM ITS DISTRIBUTOR IN NIGERIA FOR
50,000
UNITS OF ITS VISITECT CD4 350 TEST (ORDER VALUE C. £210K)
Source text for Eikon: ID:nRSP3360Ja
Further company coverage: ODX.L